Skip to main content

Table 1 Clinic-pathological data of patients with EGPA and renal involvement

From: Long-term outcomes in antineutrophil cytoplasmic autoantibody–positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients

Case Gender/Age range (years) T1/T2 (months) Onset symptom Extra-renal involvement Upro (g/24 h) EOS (%) IgE (g/l) SCr (mg/dl) Alb (g/l) MPO-ANCA (RU/ml) Renal class Crescent (%) GS (%) Interstitial EOS FPE
1 F/45-55 240/4 Asthma N/NS 1.00 20 358 4.50 45.2 674.6 Mixed 39 49 +b NA
2 F/25-35 24/24 Hemoptysis L/A/SK/N 0.10 45 217 1.47 32.4 343.5 AIN 0 0 + NA
3 F/18-25 1/1 GH N 7.80 16 976 11.00 27 20.0 Crescentic 90 0 + Extensive
4 F/55-65 600/28 Asthma L/H/NS 0.97 31 1000 1.70 43.2 28.8 Mixed 40 27 + NA
5 M/25-35 120/1 Asthma L 1.14 10 316 1.68 41.7 86.3 Focal 19 25 Segmental
6 F/45-55 408/48 Asthma L/SK 0.99 12 1000 5.90 34 161.0 Mixed 31 45 + NA
7 M/65-75 120/1 Asthma L 4.96 20 580 4.90 29 352.6 Crescentic 51 19 + Extensive
8 F/55-65 2/1 Hemoptysis L 0.50 10 200 10.50 34 180.0 Crescentic 80 0 + Segmental
9 M/45-55 9/1 Arthritis L/SK/A/N/E 0.53 21 287 9.40 37 156.4a Mixed 9 41 NA
10 M/25-35 36/36 GH N 12.30 14 1000 3.90 28.2 109.5a Mixed 46 42 + Extensive
11 M/55-65 240/1 Asthma L/NS/N 0.50 20 567 6.09 29 101.5 Focal 16 16 +b NA
12 F/45-55 600/2 Asthma L/N 5.32 11 243 2.74 26.5 222.0 Mixed 23 30.8 NA
13 M/45-55 1/1 Hemoptysis L/H 1.78 13 271 8.68 33.2 207.3 Sclerotic 10 80 + Segmental
14 F/45-55 240/1 Asthma L 4.45 14 567 6.50 25.3 384.8 Crescentic 79 21 +b NA
  1. EGPA eosinophilic granulomatosis with polyangiitis. T1 total duration, T2 duration of renal involvement, EOS eosinophilia, GS glomerular sclerosis, FPE foot process effacement, GH gross hematuria, SK skin, E eye, N sinusitis, A arthralgia, NS nervous system, L lung, H heart, AIN acute interstitial nephritis, aPR3-ANCA, beosinophilic granuloma, NA unavailable